ASMB Earnings Assembly Biosciences, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–35 of 35
| Q2 2026 | 2026-06-30 | -0.20 | 2026-08-13 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.54 | 2026-05-07 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 2.67 | 2026-03-19 | 10-K |
| FY 2025 | 2025-12-31 | -0.55 | 2026-03-19 | 10-K |
| Q3 2025 | 2025-09-30 | -0.72 | 2025-11-10 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.33 | 2025-08-06 | 10-Q |
| Q1 2025 | 2025-03-31 | -1.17 | 2025-05-08 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -1.54 | 2025-03-20 | 10-K |
| FY 2024 | 2024-12-31 | -6.69 | 2025-03-20 | 10-K |
| Q3 2024 | 2024-09-30 | -1.51 | 2024-11-07 | 10-Q |
| Q2 2024 | 2024-06-30 | -1.98 | 2024-08-08 | 10-Q |
| Q1 2024 | 2024-03-31 | -1.66 | 2024-05-08 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -1.75 | 2024-03-28 | 10-K |
| FY 2023 | 2023-12-31 | -13.38 | 2024-03-28 | 10-K |
| Q3 2023 | 2023-09-30 | -3.29 | 2023-11-08 | 10-Q |
| Q2 2023 | 2023-06-30 | -3.88 | 2023-08-09 | 10-Q |
| Q1 2023 | 2023-03-31 | -4.46 | 2023-05-04 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -5.44 | 2023-03-22 | 10-K |
| FY 2022 | 2022-12-31 | -23.08 | 2023-03-22 | 10-K |
| Q3 2022 | 2022-09-30 | -5.76 | 2022-11-08 | 10-Q |
| Q2 2022 | 2022-06-30 | -6.12 | 2022-08-09 | 10-Q |
| Q1 2022 | 2022-03-31 | -5.76 | — | — |
| FY 2021 | 2021-12-31 | -36.00 | — | — |
| Q3 2021 | 2021-09-30 | -4.92 | — | — |
| Q2 2021 | 2021-06-30 | -6.60 | 2021-08-05 | 10-Q |
| Q4 2020 | 2020-12-31 | -13.32 | 2021-02-25 | 10-K |
| Q3 2020 | 2020-09-30 | -1.08 | — | — |
| Q2 2020 | 2020-06-30 | 2.28 | 2020-08-05 | 10-Q |
| Q1 2020 | 2020-03-31 | -9.12 | 2020-05-08 | 10-Q |
| Q3 2019 | 2019-09-30 | -11.52 | 2019-11-07 | 10-Q |
| Q2 2019 | 2019-06-30 | -8.64 | 2019-08-05 | 10-Q |
| Q1 2019 | 2019-03-31 | -12.60 | 2019-05-09 | 10-Q |
| Q3 2018 | 2018-09-30 | -10.44 | — | — |
| Q2 2018 | 2018-06-30 | -15.60 | — | — |
| Q1 2018 | 2018-03-31 | -9.60 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.